Advanced form of proton therapy reduces need for feeding tubes by 50 percent
9/29/2013
A new study from researchers at The University of Texas MD Anderson Proton Therapy Center found that the use of feeding tubes in oropharyngeal carcinoma (OPC) cancer patients treated with intensity modulated proton therapy (IMPT) decreased by more than 50 percent compared to patients treated with intensity modulated radiation therapy (IMRT)...
First results from a phase III clinical trial of the combination drug, T-DM1, show that it significantly improves the length of time before the disease worsens in women with advanced HER2 positive breast cancer whose cancer has recurred or progressed despite previous treatments, including trastuzumab and lapatinib...
Preferred method identified to assess patient reactions to radiation therapy
9/28/2013
The North Shore-LIJ Health System Department of Radiation Medicine presented a novel study to evaluate the reliability of different systems used by caregivers to assess toxicity for patients receiving radiation therapy. The study presented at the 55th Annual Meeting of the American Society of Therapeutic Radiation Oncology in Atlanta, GA...
Myriad Genetics' myplan™ lung cancer test meets primary clinical endpoint
9/27/2013
Myriad Genetics, Inc. (NASDAQ: MYGN) has announced new data published in Clinical Cancer Research that showed the myPlan Lung Cancer test is a significant predictor of lung cancer death in patients with early-stage, resectable lung adenocarcinoma and may be a valuable tool for selecting which early-stage patients should be considered for additional post-surgical chemotherapy.
iCAD announces positive three-year data using the Xoft System to treat skin cancer
9/27/2013
iCAD, Inc...
Myriad Genetics' myplan™ lung cancer test meets primary clinical endpoint
9/27/2013
Myriad Genetics, Inc. (NASDAQ: MYGN) has announced new data published in Clinical Cancer Research that showed the myPlan Lung Cancer test is a significant predictor of lung cancer death in patients with early-stage, resectable lung adenocarcinoma and may be a valuable tool for selecting which early-stage patients should be considered for additional post-surgical chemotherapy...
Breast health linked to eating peanut butter and nuts
9/27/2013
By eating more peanut butter during their high school years, girls could be improving their breast health in adulthood, according to a US study published recently in the journal Breast Cancer Research and Treatment. Dr. Graham Colditz, of Washington University School of Medicine in St...
A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer...
In prostate cancer, unstable chromosomes linked to less favorable response to RT and surgery
9/27/2013
Detailed evaluation of a prostate cancer tumor biopsy may predict treatment outcomes for image-guided radiation therapy (IGRT) or surgery for prostate cancer, according to research presented at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting...
iCAD announces positive three-year data using the Xoft System to treat skin cancer
9/27/2013
iCAD, Inc...